Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012602093> ?p ?o ?g. }
- W2012602093 endingPage "1677" @default.
- W2012602093 startingPage "1671" @default.
- W2012602093 abstract "Rituximab is being used as treatment for systemic autoimmune diseases. The objective of this study was to determine whether the genetic variant in the Fc gamma-receptor III a (FCGR3A) gene, 158F/V, contributes to the observed variation in response to rituximab in patients with systemic autoimmune diseases. DNA samples from 132 Spanish patients with different systemic autoimmune diseases receiving rituximab were genotyped for FCGR3A-158F/V (rs396991) gene polymorphism using the TaqMan(®) allelic discrimination technology. Six months after infusion with rituximab we evaluated the response to the drug: 61% of the patients showed a complete response, partial 27% and 12% did not respond to the treatment. A statistically significant difference was observed in V allele frequency between responder (38%) and nonresponder (16%) patients (p=0.01; odds ratio [OR]=3.24, 95% confidence interval [CI] 1.17-11.1). Rituximab was also more effective in V allele carriers (94%) than in homozygous FF patients (81%): p=0.02; OR=3.96, 95% CI 1.10-17.68. These results suggest that FCGR3A-158F/V (rs396991) gene polymorphism play a role in the response to rituximab in autoimmune diseases. Validation of these findings in independent cohorts is warranted." @default.
- W2012602093 created "2016-06-24" @default.
- W2012602093 creator A5001977648 @default.
- W2012602093 creator A5015110699 @default.
- W2012602093 creator A5018267294 @default.
- W2012602093 creator A5029391356 @default.
- W2012602093 creator A5032455788 @default.
- W2012602093 creator A5033655356 @default.
- W2012602093 creator A5048137156 @default.
- W2012602093 creator A5054295811 @default.
- W2012602093 creator A5056556840 @default.
- W2012602093 creator A5059178520 @default.
- W2012602093 creator A5060792692 @default.
- W2012602093 creator A5073686932 @default.
- W2012602093 creator A5080331062 @default.
- W2012602093 creator A5083471235 @default.
- W2012602093 date "2012-12-01" @default.
- W2012602093 modified "2023-10-13" @default.
- W2012602093 title "Association of the<i>FCGR3A</i>-158F/V Gene Polymorphism with the Response to Rituximab Treatment in Spanish Systemic Autoimmune Disease Patients" @default.
- W2012602093 cites W1580183585 @default.
- W2012602093 cites W1587015226 @default.
- W2012602093 cites W1722716127 @default.
- W2012602093 cites W1745556869 @default.
- W2012602093 cites W1914229355 @default.
- W2012602093 cites W1969467075 @default.
- W2012602093 cites W1979336667 @default.
- W2012602093 cites W1987135399 @default.
- W2012602093 cites W1994101231 @default.
- W2012602093 cites W2000054082 @default.
- W2012602093 cites W2002079712 @default.
- W2012602093 cites W2014291562 @default.
- W2012602093 cites W2021830136 @default.
- W2012602093 cites W2021970733 @default.
- W2012602093 cites W2024564671 @default.
- W2012602093 cites W2036335844 @default.
- W2012602093 cites W2040733258 @default.
- W2012602093 cites W2044360617 @default.
- W2012602093 cites W2045961594 @default.
- W2012602093 cites W2049266087 @default.
- W2012602093 cites W2051022408 @default.
- W2012602093 cites W2057525677 @default.
- W2012602093 cites W2063340779 @default.
- W2012602093 cites W2089016290 @default.
- W2012602093 cites W2090133088 @default.
- W2012602093 cites W2099704507 @default.
- W2012602093 cites W2101185541 @default.
- W2012602093 cites W2109502548 @default.
- W2012602093 cites W2109638333 @default.
- W2012602093 cites W2124873881 @default.
- W2012602093 cites W2128402413 @default.
- W2012602093 cites W2136143076 @default.
- W2012602093 cites W2137357764 @default.
- W2012602093 cites W2140540546 @default.
- W2012602093 cites W2140966680 @default.
- W2012602093 cites W2146443366 @default.
- W2012602093 cites W2146924887 @default.
- W2012602093 cites W2150913115 @default.
- W2012602093 cites W2152676410 @default.
- W2012602093 cites W2155707112 @default.
- W2012602093 cites W2160264356 @default.
- W2012602093 cites W2163100333 @default.
- W2012602093 cites W2165591674 @default.
- W2012602093 cites W2169294950 @default.
- W2012602093 cites W2169302366 @default.
- W2012602093 cites W2170938637 @default.
- W2012602093 doi "https://doi.org/10.1089/dna.2012.1799" @default.
- W2012602093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23075294" @default.
- W2012602093 hasPublicationYear "2012" @default.
- W2012602093 type Work @default.
- W2012602093 sameAs 2012602093 @default.
- W2012602093 citedByCount "15" @default.
- W2012602093 countsByYear W20126020932014 @default.
- W2012602093 countsByYear W20126020932015 @default.
- W2012602093 countsByYear W20126020932017 @default.
- W2012602093 countsByYear W20126020932018 @default.
- W2012602093 countsByYear W20126020932019 @default.
- W2012602093 countsByYear W20126020932021 @default.
- W2012602093 countsByYear W20126020932022 @default.
- W2012602093 countsByYear W20126020932023 @default.
- W2012602093 crossrefType "journal-article" @default.
- W2012602093 hasAuthorship W2012602093A5001977648 @default.
- W2012602093 hasAuthorship W2012602093A5015110699 @default.
- W2012602093 hasAuthorship W2012602093A5018267294 @default.
- W2012602093 hasAuthorship W2012602093A5029391356 @default.
- W2012602093 hasAuthorship W2012602093A5032455788 @default.
- W2012602093 hasAuthorship W2012602093A5033655356 @default.
- W2012602093 hasAuthorship W2012602093A5048137156 @default.
- W2012602093 hasAuthorship W2012602093A5054295811 @default.
- W2012602093 hasAuthorship W2012602093A5056556840 @default.
- W2012602093 hasAuthorship W2012602093A5059178520 @default.
- W2012602093 hasAuthorship W2012602093A5060792692 @default.
- W2012602093 hasAuthorship W2012602093A5073686932 @default.
- W2012602093 hasAuthorship W2012602093A5080331062 @default.
- W2012602093 hasAuthorship W2012602093A5083471235 @default.
- W2012602093 hasConcept C104317684 @default.
- W2012602093 hasConcept C126322002 @default.
- W2012602093 hasConcept C143660080 @default.
- W2012602093 hasConcept C156957248 @default.